These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34182003)

  • 1. A2
    Gdula AM; Swiatkowska M
    Microvasc Res; 2021 Nov; 138():104218. PubMed ID: 34182003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Dual Purinoceptor-dependent Approach on Release of Vascular Endothelial Growth Factor From Human Microvascular Endothelial Cell (HMEC-1) and Endothelial Cell Condition.
    Gdula AM; Swiatkowska M
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):349-359. PubMed ID: 32569015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y
    Boncler M; Wzorek J; Wolska N; Polak D; Watala C; Rozalski M
    Vascul Pharmacol; 2019 Feb; 113():47-56. PubMed ID: 30471364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between purinergic receptors: effect of ligands for A2A and P2Y12 receptors on P2Y1 receptor function.
    Suzuki T; Obara Y; Moriya T; Nakata H; Nakahata N
    FEBS Lett; 2011 Dec; 585(24):3978-84. PubMed ID: 22079667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1.
    Desai A; Victor-Vega C; Gadangi S; Montesinos MC; Chu CC; Cronstein BN
    Mol Pharmacol; 2005 May; 67(5):1406-13. PubMed ID: 15673602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ticagrelor on endothelial calcium signalling and barrier function.
    Gündüz D; Tanislav C; Schlüter KD; Schulz R; Hamm C; Aslam M
    Thromb Haemost; 2017 Jan; 117(2):371-381. PubMed ID: 27904901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFα induces inflammatory stress response in microvascular endothelial cells via Akt- and P38 MAP kinase-mediated thrombospondin-1 expression.
    Fairaq A; Goc A; Artham S; Sabbineni H; Somanath PR
    Mol Cell Biochem; 2015 Aug; 406(1-2):227-36. PubMed ID: 25963668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic signaling induces thrombospondin-1 expression in astrocytes.
    Tran MD; Neary JT
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9321-6. PubMed ID: 16754856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.
    Jing F; Zhang Y; Long T; He W; Qin G; Zhang D; Chen L; Zhou J
    J Neuroinflammation; 2019 Nov; 16(1):217. PubMed ID: 31722730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells.
    Fischer JW; Stoll M; Hahn AW; Unger T
    Cardiovasc Res; 2001 Sep; 51(4):784-91. PubMed ID: 11530112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y
    Popielarski M; Ponamarczuk H; Stasiak M; Gdula A; Bednarek R; Wolska N; Swiatkowska M
    Biochem Biophys Res Commun; 2020 Jun; 526(3):756-763. PubMed ID: 32265027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A
    Mediero A; Wilder T; Shah L; Cronstein BN
    FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
    Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M
    Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sLRP1 (Soluble Low-Density Lipoprotein Receptor-Related Protein 1): A Novel Biomarker for P2Y12 (P2Y Purinoceptor 12) Receptor Expression in Atherosclerotic Plaques.
    Chen J; Pi S; Yu C; Shi H; Liu Y; Guo X; Zhou L; Li Y; He H; Xia Y; Mao L; Hu B
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):e166-e179. PubMed ID: 32349534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor signaling attenuates LPS-induced pro-inflammatory cytokine formation of mouse macrophages by inducing the expression of DUSP1.
    Köröskényi K; Kiss B; Szondy Z
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1461-71. PubMed ID: 27066978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A receptor as a drug discovery target.
    de Lera Ruiz M; Lim YH; Zheng J
    J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists.
    Tang J; Li MP; Zhou HH; Chen XP
    Curr Vasc Pharmacol; 2015; 13(5):566-77. PubMed ID: 25440595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin by activation of adenosine A
    Rukoyatkina N; Shpakova V; Bogoutdinova A; Kharazova A; Mindukshev I; Gambaryan S
    Biochem Biophys Res Commun; 2022 Jan; 586():20-26. PubMed ID: 34823218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-bound structure of the human P2Y12 receptor.
    Zhang J; Zhang K; Gao ZG; Paoletta S; Zhang D; Han GW; Li T; Ma L; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
    Nature; 2014 May; 509(7498):119-22. PubMed ID: 24784220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.